MTOR and prostate carcinoma: Brachydins showed cytotoxicity in PC-3 cells, affected cellcycle genes, and modulated the PI3K/AKT/mTOR pathway. pathways, suchas the PI3K/AKT/mTOR pathway, suggesting therapeutic potential forthe treatment of prostate cancer